{"title": "Targeting telomeres to overcome therapy resistance in advanced melanoma", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/gene_therapy.xml", "value": "Targeting telomeres to overcome therapy resistance in advanced melanoma"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2018/03/180321130904.htm"}], "link": "https://www.sciencedaily.com/releases/2018/03/180321130904.htm", "summary": "A study has demonstrated the efficacy of targeting aberrantly active telomerase to treat therapy-resistant melanoma.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/gene_therapy.xml", "value": "A study has demonstrated the efficacy of targeting aberrantly active telomerase to treat therapy-resistant melanoma."}, "published": "Wed, 21 Mar 2018 13:09:04 EDT", "published_parsed": [2018, 3, 21, 17, 9, 4, 2, 80, 0], "id": "https://www.sciencedaily.com/releases/2018/03/180321130904.htm", "guidislink": false}